The federal government has received a surge in complaints in recent months about failed hip replacements, suggesting that serious problems persist with some types of artificial hips even as researchers scramble to evaluate the health dangers. The New York Times reports.
The Obama administration revealed plans Tuesday to cut or roll back hundreds of federal regulations, saying it hoped to save businesses $10 billion and spur job growth.
The Food and Drug Administration is taking on an expanded mission when regulators have little hope for more funding and may even see their budgets cut, the New York Times reports.
People usually think of insider trading as illegally manipulating stock sales for huge profits. But it can also be legal. So just what is insider trading? When can it be legal? Here are the details.
The market has given investors a great opportunity to buy this stock at discount, the "Mad Money" host said.
Swiss drugs industry supplier Lonza is to buy U.S.-listed Arch Chemicals for some $1.2 billion, creating the world's largest player in the microbial control market, the groups said on Monday.
Eli Lilly signaled it could maintain or even boost research spending through 2014, even as company sales and earnings tumble due to expected generic competition for its biggest-selling medicines.
A panel of federal cancer experts says the best-selling cancer drug in the world should no longer be approved to treat breast cancer because it is ineffective and causes dangerous side effects.
The court-appointed receiver who is recovering assets for investors in Allen Stanford's alleged Ponzi scheme is demanding that Libya's sovereign wealth funds return millions of dollars they somehow managed to withdraw just before the firm blew up in 2009, CNBC has learned.
The Food and Drug Administration says some chicken meat may contain small amounts of arsenic, though the agency is stressing that the amount is too tiny to be dangerous to people who eat it.
Clay Siegall, Seattle Genetics CEO discussing the next generation of drugs in the battle against cancer.
Dificid is the first new FDA- drug approved for the infection in nearly 25 years, according to Optimer Pharmaceuticals.
Recent technology that identifies varieties of fish by their gene sequences has shown that 20 to 25 percent of seafood products are being mislabeled, the New York Times reports.
GlaxoSmithKline is seeing strong, double-digit growth from sales in emerging markets, offsetting sales declines from generic drugs in the U.S. and Europe, Chief Executive Andrew Witty told CNBC Tuesday.
Former Enron Chief Financial Officer Andy Fastow has been transferred to a Houston halfway house as he prepares to be released from prison later this year.
Blu, the maker of electronic cigarettes that release a nicotine-laden vapor instead of smoke, has developed packs of e-cigarettes with sensors that will let users know when other e-smokers are nearby, the New York Times reports.
A federal court jury has rejected Mattel Inc.'s copyright infringement claims involving MGA Entertainment's popular line of Bratz dolls and awarded MGA $88.4 million for misappropriation of its trade secrets by the Barbie-maker.
The Environmental Protection Agency and the Food and Drug Administration say that very low levels of radiation have turned up in a sample of milk from Washington state. But federal officials say consumers should not worry.
Studies suggest a link between food dyes and hyperactivity in children, the New York Times reports.
abstract goes here